The tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) is a potent inducer of differentiation in human promyelocytic leukemia cells. Recently, TPA has been successfully administered to patients with myelocytic leukemia and has produced therapeutic effects that led to temporary remission. These studies demonstrated the potential ef®cacy of TPA in cancer chemotherapy. We now seek to understand the biological effects and molecular mechanisms of differentiation in response to TPA treatment in leukemia cells by expression pro®ling using DNA microarray. Our results show distinct temporal and coordinated gene changes that are consistent with differentiation and activation of multiple biochemical pathways in HL-60 cells exposed to TPA. Alterations of gene expression in HL-60 cells include various transcription factors, cytokines and protein markers that are consistent with the induction of differentiation elicited by TPA. These temporal patterns of gene expression were abolished or greatly diminished in an HL-60 derived TPAresistant variant cell line (HL-525), thus revealing transcriptional and consequential biochemical changes that may be required for TPA-induced differentiation. In addition, certain genes were upregulated by TPA in TPA-resistant HL-525 cells but not in TPA-sensitive HL-60 cells suggesting that these genes may play a role in the resistant phenotype. These patterns of gene expression may be important for predicting response to TPA.
INTRODUCTION
12-O-tetradecanoylphorbol-13-acetate (TPA)-induced cellular differentiation of a number of leukemia cell lines including HL-60 human myeloid leukemia cells has been extensively investigated. These effects of TPA are thought, in part, to be due to the activation of protein kinase Cb (1, 2) . Induction of terminal differentiation in leukemia cells is also associated with the activation of the stress-activated protein kinase (SAPK), release of cytochrome c, activation of caspases and ultimately the induction of apoptosis (3, 4) .
Recently, exploiting its potent effects on the induction of differentiation in human leukemia cells in vitro, TPA was administered by intravenous infusions to patients with myelocytic leukemia, who were refractory to all-trans retinoic acid, cytosine arabinoside (AraC) and other chemotherapeutic drugs (5) . TPA, given alone, or in combination with vitamin D 3 and a low dose of AraC, was shown to decrease the number of myeloblasts and conferred remissions in some of these patients. It was shown further that white blood cell counts were increased to the normal range when TPA was given alone in patients with depressed white blood cell and neutrophil counts due to prior treatment with bone marrow suppressive chemotherapeutic drugs (6) . These results, although preliminary, indicated therapeutic ef®cacy for TPA in leukemic patients and also indicated its ability to overcome the marrow suppressive effects associated with the use of cytotoxic chemotherapeutic regimens.
Further molecular and genetic analyses of the effects of TPA are needed to obtain a better understanding of the mechanisms contributing to differentiation and therapeutic response. Gene expression analyses have identi®ed a number of downstream targets that are induced by TPA, and some of them may be essential for the onset of differentiation. For example, expression of the ubiquitin C-terminal hydrolase gene has been shown to be associated with TPA-induced differentiation of an acute lymphoblastic leukemia cell line, Reh, to a mature non-dividing state (7) . Differential regulation of c-myc, c-max and mxi1 expression has also been reported in leukemia cells undergoing TPA-induced differentiation (8) . Recently, the pattern of gene expression in HL-60 cells treated with TPA was examined by DNA microarray (9) . Alterations in the expression of a large number of genes were observed and some of these gene changes are in concordance with previous ®ndings of their role in differentiation. Despite these analyses, our understanding of the global mechanisms of TPAinduced differentiation is still sketchy.
In this study, we hope to gain further insights into the biological effects and molecular mechanisms of TPA-induced differentiation in leukemia cells by comparing the expression pro®les of HL-60 and its TPA-resistant derivative, HL-525 cells, in response to TPA treatment. Since HL-525 cells are resistant to TPA-induced differentiation (10) , expression pro®ling with this TPA-resistant mutant might reveal genes and pathways that are crucial for the TPA-mediated differentiation program and mechanisms of TPA resistance.
MATERIALS AND METHODS

Cell lines
HL-60 and its TPA-resistant derivative variant HL-525 cells (10) were cultured in RPMI media supplemented with 10% fetal bovine serum, penicillin (100 U/ml), streptomycin (100 mg/ml) and L-glutamine (300 mg/ml) as previously described (11) . TPA was purchased from Alexis Biochemicals (San Diego, CA). Cultured cells were grown at 37°C in a humidi®ed atmosphere of 5% CO 2 and were passed twice a week to keep the cell density under 1.5 Q 10 6 cells/ml. For the differentiation assay, HL-60 and HL-525 cells were seeded at a density of 0.2 Q 10 6 cells/ml and treated with 32 nM TPA for various times up to 48 h. At each time point, the number of viable cells was determined by trypan blue exclusion assay and cell viability was >90%. The number of adherent cells was scored in randomly selected microscopic ®eld (200-fold magni®cation) using a phase-contrast microscope (Nikon Phase-Contrast 2, Japan). The percent of adherent cells as a percentage of total viable cells, determined by trypan blue exclusion assay, was calculated for each time point.
Microarrays
Human GeneFiltersÔ arrays, GF211, were obtained from Research Genetics, Inc. (Huntsville, AL). These arrays, printed on 5 Q 7 cm nylon membranes, contained approximately 4200 expressed sequence tags (ESTs/cDNA elements) corresponding to known genes in the GenBank database. All the EST clones have been sequence veri®ed. The array also contained 192 spots of total genomic DNA and 168 housekeeping genes, which serve as reference points for the image analysis software, PathwaysÔ (Research Genetics, Inc.), for normalization and for verifying the homogeneity of the hybridization.
RNA extraction, probe preparation and labeling, hybridization and scanning RNA was extracted from the HL-60 and HL-525 cells using the Triazol reagent (LTI, Inc., Gaithersburg, MD). Qualities of all RNA samples were monitored by gel electrophoresis before further use. The labeling procedures were conducted as speci®ed by the manufacturer and details of the protocols are downloadable from the Research Genetics, Inc. web site (http://www.resgen.com). In brief, cDNA targets were synthesized from total RNA with [ 33 P]dCTP by oligo dT-primed polymerization using Superscript II reverse transcriptase (LTI, Inc.). Approximately 5 mg of total RNA samples were used in each labeling reaction. The pool of nucleotides in the labeling reaction was 0.5 mM dGTP, dATP and dTTP, and 0.2 mM dCTP. Probes were puri®ed by gel chromatography (BioSpin 6; Bio-Rad, Hercules, CA) and ethanol precipitated, and then resuspended in 100 ml of TE buffer and an aliquot was withdrawn for determination of incorporation ef®ciency. Prior to hybridization, the solution was boiled for 2 min then allowed to cool to room temperature. An equal number of counts (c.p.m.) were applied from each sample for hybridization at 46°C. At the end of hybridization, ®lters were washed for 20 min in 2Q SSC, 0.2% SDS at room temperature, and then for 30 min in 0.1Q SSC, 0.2% SDS, at 60°C. Arrays were then exposed on phosphorimage screen for the appropriate time and scanned on a Molecular Dynamics Storm Phosphorimager (Molecular Dynamics/Amersham Biosciences, Sunnyvale, CA). The scanned images were analyzed with the PathwaysÔ software.
Statistical methods
Trans-activation and -repression of gene expression may be regulated transiently, protractedly and periodically. We reasoned that these patterns of gene change might be predicted using the algorithm of polynomial functions. The gene expression data obtained were ®rst normalized after background subtraction using the PathwaysÔ software and the normalized data for each gene were then analyzed by regression models to ®t polynomial functions of the logarithm of time up to third degree for each gene. Genes that showed >2-fold changes for at least two consecutive time points were included in the polynomial regression analysis. A subset of genes with signi®cant coef®cients of the highest degree (i.e. cubic, quadratic or linear) at the signi®cance level of 2% (to control possible type-I error rate from multiple comparisons) was selected for bioinformatics searches. Moreover, local regression models were also used to ®t quadratic polynomials of the logarithm of time to ®nd genes with only a short period of peak over time. Five consecutive time points were used for the local regression model, and genes with signi®cant coef®cients of quadratic term at 0.5% signi®cance level (to further control possible type-I error rate from multiple comparisons) were selected. For the selected genes, the patterns of gene expression were log transformed, centered by median, and subjected to cluster analyses by centered correlation and average linkage as the similarity/distance metric, using the hierarchical cluster algorithm in Cluster and TreeView software suite (12) . The entire data set for the microarray experiments described in this study is available for searches and downloading at http://cinj.umdnj.edu/drug_ resistance.
RESULTS
Previous gene expression analyses using traditional molecular approaches have led to the identi®cation of a diverse number of genes that are variously implicated in TPA-induced differentiation in human leukemic cells in vitro. Recent use of DNA microarray similarly captured the expression pro®le of a large number of genes, with expected changes that correlate with previous ®ndings, as well as some unexpected altered gene expressions that are thought to be novel and possibly crucial for the effects of TPA (9) . Nevertheless, the biochemical and genetic pathways governing the differentiation program by TPA are still incompletely understood.
To further delineate the mechanisms of TPA-induced differentiation, we examined in this study the differential expression pro®les of HL-60 and its TPA-resistant variant HL-525 cells in response to TPA treatment. HL-525 cells are resistant to TPA-induced differentiation ( Fig. 1) , and genes whose expressions are altered in HL-60 but not HL-525 cells may play a role in the TPA-induced differentiation phenotype.
We ®rst monitored the expression pro®les of the HL-60 leukemia cells in response to treatment with TPA in a timecourse analysis. RNAs were isolated from cells treated with TPA at 0, 0.25, 0.5, 1, 2, 3, 6, 12, 24 and 48 h and compared with untreated controls. Samples were labeled by reverse transcription and then hybridized to cDNA arrays with 4105 genes printed on nylon membranes (Research Genetics, Inc.) (for details see Materials and Methods). Normalized data were analyzed by regression models and the expression levels for each gene were ®tted to polynomial functions relative to the logarithm of time up to the third degree for each gene. Statistically signi®cant alterations in the expression of many genes were observed as described in the Materials and Methods. A subset of them, whose functions and biological signi®cance are related to TPA action and differentiation, were selected for Cluster analysis and the results displayed by TreeView (12) . The data indicated temporal patterns of altered gene expression that can be classi®ed as early, intermediate and late response genes (Fig. 2) . The remaining genes are available as Supplementary Material for searches and downloading.
The early response genes were induced within 15 min after treatment with TPA and their expression was undetectable by 2±3 h. Some of the early response genes induced by TPA include JunD (13), FosB (14) , homeobox protein NKX2.1 (15) , transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47, tcf3) (16), Kruppel-like zinc ®nger factor (KLF4) (17) and Rab2 (18) (Fig. 2) . The onset of induction of the intermediate response genes occurred~2±3 h after TPA treatment and the expression of these genes was shut off by 12±24 h, and they include interleukin 8 (19) and the small inducible cytokines A2, A3, A4 and A7 (20) , early growth response-1 and -2 (EGR-1 and -2) (21, 22) and Pac-1 (23) (Fig. 2) . The late response genes were induced or repressed between 12 and 24 h and their expression either peaked or declined by 48 h. Some of the late genes include differentiation markers such as myeloperoxidase (24) , villin (25) , vimentin (26) and activin A (27, 28) .
As evident from the above data, several patterns of gene expression could be visually identi®ed in TPA-treated cells. We wished to develop more quantitative models that would allow us to predict whether particular genes conform to these patterns in a statistically signi®cant manner. Microarray data were analyzed by regression models to ®t the polynomial functions relative to the logarithm of time up to the third degree for all genes (see Materials and Methods). The mean fold-changes in expression of the subset of genes corresponding to those in Our results showed that TPA-induced temporal expression patterns of upregulation in HL-60 cells ®tted the polynomial functions relative to the logarithm of time (Fig. 3) . Interestingly, early response genes that were upregulated tend to be quadratic in pattern, and these genes were induced within 15 min after TPA treatment and returned to basal levels within 2±3 h (Fig. 3A) . Additionally, we observed that intermediate and late response genes also responded to TPA induction in a quadratic fashion ( Fig. 3B and C) . Since our time-course experiments did not extend beyond 48 h, extrapolation of the pattern of late response genes to later time points was not possible. Nevertheless, a cyclical pattern of gene expression that ®ts the cubical degree of the regression model was also observed (Fig. 3D) . The periodic change in the expression of these genes may implicate their association with the cell cycle (9) . In contrast, a linear pattern of expression was observed for most genes that were targeted for downregulation by TPA (data not shown). Studies on TPA-induced temporal expression of the same genes that were examined in Figure 2 in HL-60 cells (Figs 2 and 3A±D) showed that these genes were not responsive to TPA in HL-525 cells (Figs 2 and  3E±H) .
Coordinated changes in the transcriptions of various genes that shared common biochemical pathways were also found. For example, expression of TGF-b 2 ( Fig. 4B) (29) , TGF-b receptor type III (Fig. 2) (30) , TSC-22 ( Fig. 4B) (31) and activin A (Fig. 2) (32) , are coordinately regulated. Gene clusters with common biochemical pathways, such as those of the interleukin 1 signaling pathway (33) (the interleukin I receptor type I and II precursors, the interleukin 1 receptor accessory protein and the interleukin receptor 1 antagonist), calcium signaling and metabolism (34,35) (S100 calcium binding proteins A2, A3 and A8, the calcium activated potassium channel SKCA3, transient receptor potential channel 1 and calgizzarin), and cell migration and tumor-cell invasion factors (36, 37) [plasminogen activator (urokinase For the normalized expression data, regression models were used to ®t the polynomial functions relative to the logarithm of time up to the third degree for each gene. A subset of upregulated genes with signi®cant coef®cients of the highest degree (i.e. cubic, quadratic or linear) at signi®cance levels of <5% was selected for the HL-60 cells (Fig. 2) . These genes are shown in (A)±(D). The effect of TPA on the same genes was also shown for HL-525 cells (E±H). The average fold-changes for the respective cluster of genes were plotted as a function of time in relation to the sequence of their expression. The solid line represents a 2-fold cut-off for the expression levels for these genes. The time points examined in these experiments include 0, 0.25, 0.5, 1, 2, 3, 6, 12, 24 and 48 h.
To further determine the genes that are speci®cally associated with the differentiation phenotype, we investigated the expression pro®les of the HL-60 derived TPA-resistant mutant HL-525 cells (10, 40) . These cells do not undergo appreciable macrophage differentiation which is characteristic of HL-60 cells in response to TPA treatment (Fig. 1) . The HL-525 cells also exhibit defective expression in the b isotype of protein kinase C (PKCb) (41) , and introduction of wildtype PKCb has been shown to restore the capacity for differentiation in these cells (1) . Expression pro®ling by DNA microarray showed that the distinct temporal patterns of TPAinduced changes in gene expression found in the HL-60 cells were largely abolished in the HL-525 mutant in response to TPA (Figs 2 and 3E±H) , thus indicating that these clusters of genes, including JunD, FosB, EGR-1 and -2, interleukin 8, the small inducible cytokines (A2±A5) and some of the interleukin receptors may be a part of the transcription program for TPA-induced differentiation in HL-60 cells and their expressions may be mediated by PKCb.
Although there are differences in TPA-induced gene expression in HL-60 and HL-525 cells, not all of the changes in gene expression are statistically signi®cant in our analysis (Fig. 4A) . Some genes, including Ini1, colony stimulating factor 1 receptor, TGF-b 2 , the A-kinase anchoring protein 18 (AKAP18), monocyte chemotactic protein 3 and 5-lipoxygenase activating protein, were induced by TPA in both the wild-type and the TPA-resistant mutant cells, thus suggesting that they are not involved in differentiation (Fig. 4B) . The levels of induction of many of these genes in HL-525 cells, however, were lower than those in HL-60 cells. Additionally, the mutant cells also failed to exhibit the cyclical pattern of expression for TGF-b 2 that was observed in HL-60 cells (Fig. 4B) . By this approach, the temporal and coordinated changes in gene expression induced by TPA in HL-60 but not in HL-525 cells (Figs 2 and 3 ) suggest that some of these genes are involved in differentiation.
It is also apparent from the clustergram that a novel cluster of genes was induced temporally by TPA in the HL-525 cells that were unaltered in their expression in HL-60 cells [ Fig. 4A (cluster in yellow box) and C and Table 1 ]. It is possible that the upregulation of these genes plays a role in the TPAresistant phenotype of HL-525 cells. Genes induced by TPA in HL-525 cells include the stress-activated protein kinase, SAPK/JNK1 (42), JNKK2, (43), the erythrocyte membrane protein band 4.1 (protein 4.1) (44), the DEAD-box RNA helicase, DDX3 (45), p110 subunit of eIF-3 (46) and the transcription factor GATA-6 (47) (Fig. 4C) .
Coordinated changes were also observed in the mutant cells treated with TPA, which include a cluster of genes involved in protein folding, transport and secretion [heat shock cognate 71 kDa protein (48); Rab7, involved in endocytic protein transport (49) ; the signal sequence receptor d subunit (translocon-associated protein d) (50); TAP, the human homolog of Mex67p that mediates CTE-dependent RNA export from the nucleus (51); the p110 subunit of eIF-3, a Nip1 homolog in yeast required for nuclear export (46) ; and huntingtin, involved in microtubule-mediated transport or vesicle function (52)], and the parallel expression of the signal transduction cluster SAPK/JNK1 and JNKK2. Induction of proteases, such as caspase-4 and -10, and the ®broblast activating protein, which is a dipeptidyl peptidase and gelatinase (53) , by TPA were also found in HL-525, but not in HL-60 cells. Furthermore, changes in the expression of some genes in HL-525 cells induced by TPA, including the DEAD-box RNA helicase, cullin, vacuolar H + -ATPase, coronin-like protein (actin-binding protein), ATP synthase g subunit (H-type), NUP 88 (nucleoporin), ADP ribosylation factor 4 and the ADP/ATP mitochondrial carrier protein, are functionally similar to those in Caenorhabditis elegans that are required for cell division (54) , thus indicating that the mutant cells responded to TPA differently from the wild-type cells and were not differentiating.
DISCUSSION
Gene expression induced by TPA has been examined extensively. Many genes have been serially identi®ed over the years that are thought to be part of the transcription program for TPA-induced differentiation. Nevertheless, the mechanisms of the temporal changes in gene expression and the subset of genes required for differentiation are still not fully appreciated. Previous microarray analysis of TPA-induced differentiation of HL-60 cells resulted in the identi®cation of a large number of genes that showed altered expression (9). However, samples were only pro®led at 0.5, 4 and 24 h after TPA treatment. Therefore, given the few time points examined in that study, more subtle patterns of the induction of gene expression by TPA were not effectively captured.
We report here more detailed time-course analyses and comparative expression pro®ling of the effects of TPA in HL-60 and its TPA-resistant mutant derivative HL-525 cells. Application of the algorithm of polynomial functions for regression modeling (see Materials and Methods) facilitated the identi®cation of distinct temporal alterations in gene expression that can be distinguished as early-, intermediateand late-response genes upon TPA treatment (Figs 2 and 3) . TPA-induced sequential gene changes also seem to be hierarchical and coordinated. TPA treatment resulted in the induction of a cluster of mostly transcription factors and also growth factor stimulators leading the cascade in the early response phase, followed by the expression of a group of chemotactic factors and chemoattractants, some transcription factors, growth factors and protein kinases and phosphatases at the intermediate phase, and ®nally the coordinated response of genes of various biochemical pathways with distinct functional properties including maintenance of differentiation in the late phase in HL-60 cells. The transcription pro®le is also pyramidal, with a small number of genes activated in the early response cluster at the apex, followed by a modest, but substantial, increase in the intermediate cluster and a large number of late genes that confer and maintain the differentiation phenotype.
Early gene changes involving transcription factors such as JunD, FosB, EGR-1 and -2, KLF4 and TCF3 (Fig. 2 ) are in agreement with those reported in the literature. The expression of JunD has been shown to be associated with cell growth inhibition, which is consistent with the growth arrest observed with HL-60 cells undergoing differentiation (55) . Increased expression of the transcription factors TCF3, which forms heterodimers with tissue-speci®c basic helix-loop-helix proteins and regulates early B-cell differentiation (19) , and KLF4, which binds the CACCC core sequence and controls differentiation of epithelial cells (20) , may further trigger the transcription of various downstream target genes that form the clusters of intermediate and late response genes. Some of these downstream gene changes observed in our results, including the downregulation of myeloperoxidase (25) and CD31 (56), increased expression of activin A (32), vimentin (27) , ®lamin (39) , the hematopoietic proteoglycan core protein (57), matrix metalloproteinase 2 (38) and its substrate galectin 3 (58, 59) , are indicative of TPA induced differentiation of HL-60 cells (Fig. 2) (60) .
More importantly, comparative analysis between HL-60 and the TPA-resistant mutant HL-525 cells enabled us to identify the genes that may have speci®c roles in TPA-induced differentiation (Figs 2 and 3) . Except for PKCb, expression of various PKC isozymes (PKCa, -b, -g, -d, e and -z) is comparable between HL-60 and HL-525 cells (41) . Since HL-525 cells exhibit defective expression of PKCb, we conclude that: (i) genes that were induced by TPA in HL-60 but not in HL-525 cells may be mediated by PKCb; (ii) some of these genes may have speci®c roles in differentiation; (iii) genes that were induced by TPA in both HL-60 and HL-525 cells may not be important for differentiation; and (iv) genes selectively induced in HL-525 cells may play a role in preventing TPA-induced differentiation.
In addition to the de®ciency in PKCb, HL-525 cells are also defective in the expression of a myeloid-speci®c X-linked protein kinase, PRKX (61, 62) . It was shown further that PRKX is required for TPA-induced differentiation in HL-60 cells. PRKX expression is induced by TPA but requires the presence of PKCb. Restoration of PRKX expression in the PKCb-de®cient HL-525 cells renders them sensitive to TPAinduced differentiation that is independent of PKCb (62) . Therefore, it is likely that the genes that are required for TPA-induced differentiation are downstream targets of PRKX.
With the loss of PKCb, HL-525 responded to TPA differently from the wild-type HL-60 cells. The coordinated regulation of SAPK/JNK1, JNNK2 and MAP kinase 1, in HL-525 cells suggests a stress response to TPA (63) . It has been shown that JNK1 in¯uences the basal (unstimulated) growth of the human glioblastoma T98G cells (64) , thus raising the possibility that activation of the SAPK and MAP kinase pathways may deter HL-525 cells from undergoing TPAinduced differentiation. Additionally, we observed that some of the TPA-induced gene changes in HL-525 cells are functionally similar to some genes in C.elegans that are required for cell division (54) . Functional characterization of genes on chromosome III of the C.elegans genome using RNA-mediated interference and differential interference contrast microscopy revealed a subset of genes on this chromosome that are essential for proper cell division. Some of these genes induced by TPA in HL-525 cells include the DEAD-box RNA helicase, cullin, vacuolar H + -ATPase, coronin-like protein (actin-binding protein), ATP synthase g subunit (H-type), NUP 88 (nucleoporin), ADP ribosylation factor 4 and the ADP/ATP mitochondrial carrier protein, all genes demonstrated to participate in cell division in C.elegans (54), further supporting that HL-525 cells did not undergo differentiation in response to TPA but continued on a course of normal growth.
Genes that are induced by TPA in both wild-type and mutant HL-60 cells, by this comparison, may not have roles in TPA-induced differentiation. For example, the rapid onset of induction of Ini1, which encodes a subunit of the SWI/SNF complex involving in ATP-dependent chromatin remodeling that facilitates the access of transcription factors to regulatory DNA sequences (65) , in both HL-60 and HL-525 cells by TPA implicates the central role of Ini1 in priming the genome for the ensuing wave of gene expression mediated by the early response transcription factors, but excludes its role in TPA-induced differentiation.
We also realized that the transcription pro®les observed with the HL-525 mutant might not be entirely in¯uenced by the mutation in the PKCb signaling pathway. It is likely that additional mutations might have been acquired in response to the selection with TPA, thereby giving rise to the unique expression pro®les that may implicate their association with the resistance to differentiation, the stress response, and the incomplete erythrocytic differentiation pathway in response to TPA in HL-525 cells.
TPA-induced expression of most genes found in this study, including EGR-1 and -2, the diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor), the small inducible cytokine A3 (macrophage in¯ammatory protein 1 a), TGF-b 2 , interleukin 8, activin A, myeloperoxidase, the proteases and various other genes, are in concordance with those in the literature as well as those reported in another expression pro®ling analysis (9) . We have also identi®ed gene changes that are not in agreement with published results. For example, Rantes, a chemokine that may play an autocrine role in mediating TPA-induced terminal differentiation, was found to be downregulated in response to TPA in our study, instead of being upregulated as reported earlier (66) . The reason for this discrepancy is not known.
Querying the patterns of gene changes in response to TPA using DNA microarray has yielded a lucid chronological expression pro®le of TPA-induced differentiation and implication for the biological mechanisms of differentiation. Querying the transcription pro®le of the TPA-resistant cells lends further insights into genes that are involved in differentiation and the failure to elicit the expression of these genes in response to the TPA may be indicative of resistance to TPA-induced differentiation. In addition, selective TPAinduced expression of certain genes in the TPA-resistant cell line but not in TPA-sensitive cells may be important for the TPA-resistant phenotype. Clearly, with increasing clinical administration of TPA in patients, the signature expression pro®les captured from our study may provide further understanding of the potential mechanisms of TPA resistance and ultimately may be predictive of response in the treatment myeloid leukemias.
